
Andrew Minett
Dr Andrew Minett is an associate professor at the School of Chemical and Biomolecular Engineering at the University of Sydney.
Dr Andrew Minett is an associate professor at the School of Chemical and Biomolecular Engineering at the University of Sydney.
Rank | Company | # | |
---|---|---|---|
131st | ![]() |
Hazer Group | $3.32m |
138th | ![]() |
Douugh | $2.69m |
139th | ![]() |
Advanced Health Intelligence | $2.68m |
141st | ![]() |
International Equities Corporation | $2.60m |
142nd | ![]() |
Argenica Therapeutics | $2.60m |
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
1353rd | Uvre">Uvre | -39.37% | 0% |
1354th | Manhattan Corporation">Manhattan Corporation | -39.66% | -16.58% |
1355th | Hazer Group">Hazer Group | -39.69% | 0.26% |
1356th | 8Common">8Common | -39.93% | -20.71% |
1357th | Aspermont">Aspermont | -39.98% | -9.45% |
Position | Company | Year | Company's current rank |
---|---|---|---|
Chair, Science Advisory Committee
|
2016 - 2018 | 131 |